NCT00021346View on ClinicalTrials.gov

Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 1997

Primary Completion Date

July 31, 2001

Study Completion Date

March 31, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

carboplatin

DRUG

gemcitabine hydrochloride

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00021346 - Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter